Genmab — Februar 2021
-
Ok - gotcha. I’ve been looking at the quarterly nos. Your approach makes more sense
-
A reduction of nearly 10% - translating into 2-2,5%points deducted from the 20%
-
It all adds up. That is a truly nasty piece of work from JJ
-
@StockBull
are you now talking about where Pagano menioned that difference of DKK900m for FX and royalty reduction and you split that in 2? or did they really mention the 450 somewhere? -
Hvis de så finder en medarbejder der ligefrem er genial så de begynder at lave afkast af deres overskydende kapital så er det jo lige pludselig fuldstændig uvæsentligt om de skal betale almisser for forlænget patent. De kunne jo starte med at købe aktier i HALO og Horizon, eller rettere det skulle de have gjort for længe siden og så købe flere af deres egne aktier, alt andet i dette marked giver ikke mening. Start tro på jer selv og køb jeres egne "børn"!
-
speaking this DKK900 million to be equally split against these two items.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind